JP2017524031A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017524031A5 JP2017524031A5 JP2017521620A JP2017521620A JP2017524031A5 JP 2017524031 A5 JP2017524031 A5 JP 2017524031A5 JP 2017521620 A JP2017521620 A JP 2017521620A JP 2017521620 A JP2017521620 A JP 2017521620A JP 2017524031 A5 JP2017524031 A5 JP 2017524031A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- subject
- gamma delta
- pharmaceutical composition
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201412175A GB201412175D0 (en) | 2014-07-09 | 2014-07-09 | Gamma T cells and uses thereof |
| GB1412175.0 | 2014-07-09 | ||
| GB201415379A GB201415379D0 (en) | 2014-08-29 | 2014-08-29 | Gamma T cells and uses thereof |
| GB1415379.5 | 2014-08-29 | ||
| GBGB1506423.1A GB201506423D0 (en) | 2015-04-15 | 2015-04-15 | Gamma delta T cells and uses thereof |
| GB1506423.1 | 2015-04-15 | ||
| PCT/GB2015/051985 WO2016005752A1 (en) | 2014-07-09 | 2015-07-08 | Gamma delta t cells and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020115432A Division JP2020172522A (ja) | 2014-07-09 | 2020-07-03 | ガンマデルタｔ細胞およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017524031A JP2017524031A (ja) | 2017-08-24 |
| JP2017524031A5 true JP2017524031A5 (enExample) | 2018-08-16 |
Family
ID=53776892
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017521620A Pending JP2017524031A (ja) | 2014-07-09 | 2015-07-08 | ガンマデルタｔ細胞およびその使用 |
| JP2020115432A Pending JP2020172522A (ja) | 2014-07-09 | 2020-07-03 | ガンマデルタｔ細胞およびその使用 |
| JP2023088259A Pending JP2023123437A (ja) | 2014-07-09 | 2023-05-29 | ガンマデルタｔ細胞およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020115432A Pending JP2020172522A (ja) | 2014-07-09 | 2020-07-03 | ガンマデルタｔ細胞およびその使用 |
| JP2023088259A Pending JP2023123437A (ja) | 2014-07-09 | 2023-05-29 | ガンマデルタｔ細胞およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20170196910A1 (enExample) |
| EP (1) | EP3167050A1 (enExample) |
| JP (3) | JP2017524031A (enExample) |
| KR (1) | KR20170045205A (enExample) |
| CN (1) | CN107075480A (enExample) |
| AU (1) | AU2015287456A1 (enExample) |
| BR (1) | BR112017000464A2 (enExample) |
| CA (1) | CA2954546A1 (enExample) |
| EA (1) | EA201790010A1 (enExample) |
| IL (1) | IL249970B (enExample) |
| SG (1) | SG11201700134PA (enExample) |
| WO (1) | WO2016005752A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201506423D0 (en) | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| US10532064B2 (en) * | 2014-08-12 | 2020-01-14 | The University Of Hong Kong | Biophosphonate compounds and gamma delta T cell-mediated therapy for treating epstein-barr virus-associated disorders |
| GB201507368D0 (en) | 2015-04-30 | 2015-06-17 | Ucl Business Plc | Cell |
| WO2018023111A1 (en) * | 2016-07-29 | 2018-02-01 | New York University | Gamma delta t cells as a target for treatment of solid tumors |
| WO2018055191A1 (en) * | 2016-09-26 | 2018-03-29 | Tessa Therapeutics Pte. Ltd. | T cell expansion method |
| TWI687227B (zh) * | 2017-10-03 | 2020-03-11 | 生倍科技股份有限公司 | 用於t細胞免疫療法之組合及其用途 |
| EP3743081A4 (en) | 2018-01-23 | 2021-12-01 | New York University | SPECIFIC ANTIBODIES OF THE DELTA 1 CHAIN OF THE T-LYMPHOCYTE RECEPTOR |
| WO2020065584A1 (en) * | 2018-09-27 | 2020-04-02 | Phosphogam, Inc. | Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells |
| AU2019354395A1 (en) | 2018-10-01 | 2021-05-06 | Adicet Therapeutics, Inc. | Compositions and methods regarding engineered and non-engineered γδ -T cells for treatment of solid tumors |
| KR20210070330A (ko) | 2018-10-01 | 2021-06-14 | 아디셋 바이오, 인크. | 혈액 종양의 치료를 위한 조작된 및 비-조작된 γδ-T 세포에 관한 조성물 및 방법 |
| EP4434541A3 (en) | 2019-01-23 | 2025-02-26 | New York University | Antibodies specific to delta 1 chain of t cell receptor |
| WO2021016652A1 (en) * | 2019-07-29 | 2021-02-04 | The University Of Melbourne | METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS |
| WO2021073290A1 (en) * | 2019-10-17 | 2021-04-22 | The University Of Hong Kong | Methods to prepare v-t cells derived exosomes for treatment of epstein-barr virus-associated cancers |
| EP4114415A1 (en) | 2020-03-06 | 2023-01-11 | Sorrento Therapeutics, Inc. | Innate immunity killer cells targeting psma positive tumor cells |
| EP4183871A1 (en) | 2021-11-23 | 2023-05-24 | Université d'Aix-Marseille | Process for preparing a composition comprising a combined cell population |
| KR20230105166A (ko) * | 2022-01-03 | 2023-07-11 | 주식회사 이뮤노맥스 | 감마-델타 t 세포의 증식 배양 방법 |
| IL314940A (en) | 2022-02-16 | 2024-10-01 | Priothera Sas | Methods of treatment with car cells in combination with s1p receptor modulators |
| DE102022132083B4 (de) | 2022-12-02 | 2024-08-22 | Horia Hulubei National Institute for R & D in Physics and Nuclear Engineering (IFIN-HH) | Vorrichtung zum Porieren und zum Beladen von Zellen sowie Verfahren hierfür |
| DE102022132082B4 (de) | 2022-12-02 | 2024-08-08 | Horia Hulubei National Institute for R & D in Physics and Nuclear Engineering (IFIN-HH) | Verfahren zur Herstellung von genetisch transfizierten und mit Nanopartikeln und/oder einem zytotoxischen Stoff beladenen immunokompetenten Zellen sowie immunokompetente Zellen und medizinische Zusammensetzung. |
| DE102022132084B4 (de) | 2022-12-02 | 2024-08-22 | Horia Hulubei National Institute for R & D in Physics and Nuclear Engineering (IFIN-HH) | Vorrichtung zum Porieren und zum Beladen von Zellen sowie Verfahren hierfür |
| WO2025046256A1 (en) | 2023-08-31 | 2025-03-06 | Universite D'aix-Marseille | Process for preparing a composition comprising a combined cell population |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2360046A1 (en) * | 1999-01-28 | 2000-08-03 | Lawrence S. Lamb, Jr. | In vitro activated gamma delta lymphocytes |
| CA2405050C (en) * | 2000-04-03 | 2010-06-15 | Hemosol Inc. | Production of tcr gamma delta t cells |
| PL211125B1 (pl) | 2000-09-11 | 2012-04-30 | Novartis Vaccines & Diagnostic | Pochodne chinolinonu jako inhibitory kinazy tyrozynowej, kompozycje je zawierające i ich zastosowanie |
| JPWO2006006720A1 (ja) | 2004-07-13 | 2008-05-01 | 株式会社メディネット | γδＴ細胞の培養方法、γδＴ細胞及び治療・予防剤 |
| CN100591761C (zh) * | 2004-08-19 | 2010-02-24 | 加的夫大学学院咨询有限公司 | 呈递抗原的人γδT细胞的制备和在免疫治疗中的用途 |
| US8153426B2 (en) * | 2004-08-19 | 2012-04-10 | University College Cardiff Consultants Limited | Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy |
| US8609410B2 (en) | 2005-09-08 | 2013-12-17 | Medinet Co., Ltd. | Method for activation treatment of antigen-presenting cell |
| WO2008152822A1 (ja) * | 2007-06-15 | 2008-12-18 | Medinet Co., Ltd. | 医薬 |
-
2015
- 2015-07-08 CA CA2954546A patent/CA2954546A1/en not_active Abandoned
- 2015-07-08 WO PCT/GB2015/051985 patent/WO2016005752A1/en not_active Ceased
- 2015-07-08 KR KR1020177003596A patent/KR20170045205A/ko not_active Withdrawn
- 2015-07-08 CN CN201580037383.2A patent/CN107075480A/zh active Pending
- 2015-07-08 EA EA201790010A patent/EA201790010A1/ru unknown
- 2015-07-08 US US15/325,012 patent/US20170196910A1/en not_active Abandoned
- 2015-07-08 SG SG11201700134PA patent/SG11201700134PA/en unknown
- 2015-07-08 AU AU2015287456A patent/AU2015287456A1/en not_active Abandoned
- 2015-07-08 JP JP2017521620A patent/JP2017524031A/ja active Pending
- 2015-07-08 BR BR112017000464A patent/BR112017000464A2/pt not_active Application Discontinuation
- 2015-07-08 EP EP15745544.5A patent/EP3167050A1/en not_active Withdrawn
-
2017
- 2017-01-08 IL IL24997017A patent/IL249970B/en active IP Right Grant
-
2020
- 2020-04-27 US US16/859,954 patent/US20210030794A1/en not_active Abandoned
- 2020-07-03 JP JP2020115432A patent/JP2020172522A/ja active Pending
-
2023
- 2023-05-29 JP JP2023088259A patent/JP2023123437A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017524031A5 (enExample) | ||
| JP2016501013A5 (enExample) | ||
| CY1123343T1 (el) | Παραγωγη μιας τραπεζας μεσεγχυματικων στρωματικων κυτταρων απο τα ομαδοποιημενα μονοπυρηνα κυτταρα πολλαπλων δοτων μυελου των οστων | |
| WO2016004305A3 (en) | Inhibitors of bruton's tyrosine kinase | |
| WO2015048689A8 (en) | Inhibitors of bruton's tyrosine kinase | |
| HK1203489A1 (en) | Purinone compounds as kinase inhibitors | |
| MX2017015574A (es) | Inhibidores de tirosina quinasa de bruton. | |
| MX351975B (es) | Composiciones y metodos para el tratamiento de infecciones y tumores. | |
| EP4269601A3 (en) | Modified t cells and methods of making and using the same | |
| WO2014153115A3 (en) | Compositions and methods for reprogramming hematopoietic stem cell lineages | |
| MX2020005849A (es) | Células madre y progenitoras hematopoyéticas humanas cd34+ modificadas con crispr-cas9 y sus usos. | |
| EA201591403A1 (ru) | Спиролактамные модуляторы рецептора nmda и их применение | |
| MA37206B1 (fr) | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EP4353254A3 (en) | Methods for treating skin infection by administering an il-4r antagonist | |
| MX2016014548A (es) | Moleculas de fusion derivadas de la toxina colix para suministro oral de una carga biologicamente activa. | |
| EA201792487A1 (ru) | Композиции гидроксипропил-бета-циклодекстринов и способы | |
| CO2018012506A2 (es) | Composiciones farmacéuticas y regímenes de dosificación para el uso clínico de anticuerpos contra el antígeno 2 de las células dendríticas de la sangre | |
| BR112016001544A8 (pt) | composições farmacêuticas para a administração intraocular que compreende um agente antibacteriano e um agente anti-inflamatório | |
| EA202091308A1 (ru) | Модифицированный вакцинный штамм brucella для лечения бруцеллеза | |
| WO2016048861A3 (en) | Heterocyclic compounds and use thereof | |
| GB201013215D0 (en) | Expression of antibody or a fragment thereof in lactobacillus | |
| BR112019000837A2 (pt) | células miméticas de célula b | |
| WO2019113375A3 (en) | Dosing regimens for the mobilization of hematopoietic stem and progenitor cells | |
| MX2018005226A (es) | Formulaciones de anticuerpo anti-factor d. | |
| MX382563B (es) | Formas cristalinas de bilastina y procedimientos para su preparacion. |